PL2998296T3 - Pochodna kwasu cykloalkilowego, sposób jej otrzymywania i jej zastosowanie farmaceutyczne - Google Patents
Pochodna kwasu cykloalkilowego, sposób jej otrzymywania i jej zastosowanie farmaceutyczneInfo
- Publication number
- PL2998296T3 PL2998296T3 PL14798044T PL14798044T PL2998296T3 PL 2998296 T3 PL2998296 T3 PL 2998296T3 PL 14798044 T PL14798044 T PL 14798044T PL 14798044 T PL14798044 T PL 14798044T PL 2998296 T3 PL2998296 T3 PL 2998296T3
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- acid derivative
- pharmaceutical application
- cycloalkyl acid
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
- C07C321/24—Thiols, sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
- C07C321/28—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310174990 | 2013-05-13 | ||
| EP14798044.5A EP2998296B1 (en) | 2013-05-13 | 2014-04-29 | Cycloalkyl acid derivative, preparation method thereof, and pharmaceutical application thereof |
| PCT/CN2014/076447 WO2014183555A1 (zh) | 2013-05-13 | 2014-04-29 | 环烷基甲酸类衍生物、其制备方法及其在医药上的应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2998296T3 true PL2998296T3 (pl) | 2018-12-31 |
Family
ID=51897690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14798044T PL2998296T3 (pl) | 2013-05-13 | 2014-04-29 | Pochodna kwasu cykloalkilowego, sposób jej otrzymywania i jej zastosowanie farmaceutyczne |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9637484B2 (pl) |
| EP (1) | EP2998296B1 (pl) |
| JP (1) | JP6440690B2 (pl) |
| KR (1) | KR102240158B1 (pl) |
| CN (1) | CN104470898B (pl) |
| AU (1) | AU2014267974B2 (pl) |
| BR (1) | BR112015027303B1 (pl) |
| CA (1) | CA2923269C (pl) |
| CY (1) | CY1120515T1 (pl) |
| DK (1) | DK2998296T3 (pl) |
| ES (1) | ES2668721T3 (pl) |
| HU (1) | HUE037512T2 (pl) |
| LT (1) | LT2998296T (pl) |
| MX (1) | MX362747B (pl) |
| NO (1) | NO2998296T3 (pl) |
| PL (1) | PL2998296T3 (pl) |
| PT (1) | PT2998296T (pl) |
| TR (1) | TR201807104T4 (pl) |
| TW (1) | TWI654172B (pl) |
| WO (1) | WO2014183555A1 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS60749B1 (sr) * | 2015-05-27 | 2020-10-30 | Jiangsu Hengrui Medicine Co | Natrijumova so inhibitora transportera mokraćne kiseline i njen kristalni oblik |
| US20190112317A1 (en) | 2015-10-05 | 2019-04-18 | The Trustees Of Columbia University In The City Of New York | Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies |
| WO2017097182A1 (zh) * | 2015-12-07 | 2017-06-15 | 成都海创药业有限公司 | 喹啉类化合物及其制备方法和作为尿酸盐转运体抑制剂类药物的用途 |
| CN107286156A (zh) * | 2016-04-05 | 2017-10-24 | 江苏新元素医药科技有限公司 | 新型urat1抑制剂及其在医药上的应用 |
| WO2018090921A1 (zh) | 2016-11-16 | 2018-05-24 | 江苏新元素医药科技有限公司 | Urat1抑制剂及其应用 |
| CN108201529B (zh) * | 2016-12-16 | 2021-10-08 | 江苏恒瑞医药股份有限公司 | 一种含有尿酸转运蛋白抑制剂的药物组合物及其制备方法 |
| CA3083295C (en) | 2017-11-23 | 2021-05-04 | Medshine Discovery Inc. | Crystal form of urat1 inhibitor, and preparation method therefor |
| CN110452168B (zh) * | 2018-05-07 | 2022-03-15 | 中国医学科学院药物研究所 | N-苯基-n-喹啉羧酸类化合物及其制法和药物用途 |
| CN110467571B (zh) * | 2018-05-11 | 2021-02-26 | 江苏恒瑞医药股份有限公司 | 一种制备环烷基甲酸类衍生物或其可药用盐的方法 |
| JP2022505976A (ja) * | 2018-11-02 | 2022-01-14 | ジエンス ヘンルイ メデイシンカンパニー リミテッド | 痛風または高尿酸血症の治療のための薬剤の調製における化合物ａおよび化合物ｂの併用 |
| CN111943957B (zh) * | 2019-05-17 | 2023-01-06 | 中国医学科学院药物研究所 | 喹啉甲酰胺类化合物及其制备方法和用途 |
| CN114315705B (zh) * | 2020-09-29 | 2024-02-20 | 杭州中美华东制药有限公司 | 一类urat1抑制剂及其制备方法与用途 |
| AU2023285760B2 (en) * | 2021-05-19 | 2025-07-10 | Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd. | Quinoline Mercaptoacetate Sulfonamide Derivative, Intermediate, Pharmaceutical Derivative Or Formulation, And Preparation Method And Use Therefor |
| CN115385854B (zh) * | 2021-05-19 | 2024-04-09 | 江苏正大清江制药有限公司 | 一种喹啉巯乙酸磺酰胺类衍生物的制备及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0112834D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| AR051780A1 (es) | 2004-11-29 | 2007-02-07 | Japan Tobacco Inc | Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos |
| TW200716132A (en) | 2005-05-03 | 2007-05-01 | Smithkline Beecham Corp | Novel chemical compounds |
| MX2009010517A (es) | 2007-04-05 | 2009-10-19 | Amgen Inc | Moduladores de cinasa aurora y metodos de uso. |
| WO2008153129A1 (ja) | 2007-06-14 | 2008-12-18 | Teijin Pharma Limited | 尿酸値低下剤 |
| BRPI0819847B1 (pt) | 2007-11-27 | 2022-01-11 | Ardea Biosciences, Inc | Compostos e composições |
| WO2010044403A1 (ja) | 2008-10-15 | 2010-04-22 | キッセイ薬品工業株式会社 | ５員環ヘテロアリール誘導体及びその医薬用途 |
| JP5806221B2 (ja) | 2009-10-13 | 2015-11-10 | ウェルスタット セラピューティクス コーポレイション | 尿酸を減少させる３−置換化合物 |
| AR081930A1 (es) * | 2010-06-16 | 2012-10-31 | Ardea Biosciences Inc | Compuestos de tioacetato |
| BR112012032193A2 (pt) * | 2010-06-16 | 2019-09-24 | Ardea Biosciences Inc | composto, composiçoes e métodos de uso de feniltioacetato |
-
2014
- 2014-04-29 HU HUE14798044A patent/HUE037512T2/hu unknown
- 2014-04-29 MX MX2015015393A patent/MX362747B/es active IP Right Grant
- 2014-04-29 NO NO14798044A patent/NO2998296T3/no unknown
- 2014-04-29 TR TR2018/07104T patent/TR201807104T4/tr unknown
- 2014-04-29 CA CA2923269A patent/CA2923269C/en active Active
- 2014-04-29 JP JP2016513214A patent/JP6440690B2/ja active Active
- 2014-04-29 US US14/889,563 patent/US9637484B2/en active Active
- 2014-04-29 ES ES14798044.5T patent/ES2668721T3/es active Active
- 2014-04-29 LT LTEP14798044.5T patent/LT2998296T/lt unknown
- 2014-04-29 PL PL14798044T patent/PL2998296T3/pl unknown
- 2014-04-29 AU AU2014267974A patent/AU2014267974B2/en active Active
- 2014-04-29 WO PCT/CN2014/076447 patent/WO2014183555A1/zh not_active Ceased
- 2014-04-29 BR BR112015027303-3A patent/BR112015027303B1/pt active IP Right Grant
- 2014-04-29 DK DK14798044.5T patent/DK2998296T3/en active
- 2014-04-29 KR KR1020157034797A patent/KR102240158B1/ko active Active
- 2014-04-29 PT PT147980445T patent/PT2998296T/pt unknown
- 2014-04-29 CN CN201480001853.5A patent/CN104470898B/zh active Active
- 2014-04-29 EP EP14798044.5A patent/EP2998296B1/en active Active
- 2014-05-09 TW TW103116499A patent/TWI654172B/zh active
-
2018
- 2018-06-13 CY CY20181100621T patent/CY1120515T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201443010A (zh) | 2014-11-16 |
| PT2998296T (pt) | 2018-06-15 |
| HK1205118A1 (zh) | 2015-12-11 |
| EP2998296A1 (en) | 2016-03-23 |
| US20160108035A1 (en) | 2016-04-21 |
| HUE037512T2 (hu) | 2018-08-28 |
| TWI654172B (zh) | 2019-03-21 |
| TR201807104T4 (tr) | 2018-06-21 |
| EP2998296A4 (en) | 2016-12-14 |
| DK2998296T3 (en) | 2018-05-22 |
| US9637484B2 (en) | 2017-05-02 |
| MX2015015393A (es) | 2016-03-15 |
| NO2998296T3 (pl) | 2018-08-11 |
| MX362747B (es) | 2019-02-05 |
| BR112015027303A2 (pl) | 2017-09-05 |
| BR112015027303B1 (pt) | 2023-04-25 |
| AU2014267974B2 (en) | 2018-08-30 |
| KR20160006207A (ko) | 2016-01-18 |
| WO2014183555A1 (zh) | 2014-11-20 |
| JP6440690B2 (ja) | 2018-12-19 |
| LT2998296T (lt) | 2018-08-10 |
| ES2668721T3 (es) | 2018-05-21 |
| CN104470898A (zh) | 2015-03-25 |
| AU2014267974A1 (en) | 2015-11-12 |
| CN104470898B (zh) | 2016-04-06 |
| KR102240158B1 (ko) | 2021-04-15 |
| CA2923269A1 (en) | 2014-11-20 |
| EP2998296B1 (en) | 2018-03-14 |
| CA2923269C (en) | 2023-02-14 |
| CY1120515T1 (el) | 2019-07-10 |
| JP2016520072A (ja) | 2016-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE037512T2 (hu) | Cikloalkilsav-származék, eljárás elõállítására, és felhasználása gyógyszerként | |
| PL3061747T3 (pl) | Pochodne ketonów pirydynowych, sposób ich wytwarzania i ich zastosowanie farmaceutyczne | |
| ZA201603889B (en) | N-benzyl tryptanthrin derivative, and preparation method and application thereof | |
| EP3040331A4 (en) | Tetrahydrocyclopentapyrrole derivative and preparation method therefor | |
| EP2947084B8 (en) | Five-and-six-membered heterocyclic compound, and preparation method, pharmaceutical composition and use thereof | |
| ZA201604328B (en) | 1,2-naphthoquinone derivative and method for preparing same | |
| SMT201900573T1 (it) | Derivati di pirazolopirimidone o pirrolotriazone, metodo di preparazione degli stessi, e applicazioni farmaceutiche degli stessi | |
| ZA201601343B (en) | Vancomycin derivative, and preparation method and application thereof | |
| EP3072895A4 (en) | Phillygenol sulphate and derivative thereof, and preparation method and application thereof | |
| EP3037099A4 (en) | Pharmaceutical composition, preparation method therefor and use thereof | |
| GB201318686D0 (en) | Pharmaceutical preparations | |
| ZA201600027B (en) | Pharmaceutical preparation | |
| EP2952519A4 (en) | PROTOPANOXADIOL DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF | |
| EP3040067A4 (en) | Chlorogenic acid powder-injection and preparation method thereof | |
| GB201301721D0 (en) | Pharmaceutical Preparations | |
| EP3000807A4 (en) | Mercaptonicotinic acid compound and preparation method and use thereof | |
| IL240447A (en) | Propionic Acid-Baryl Acid Derivatives and Their Use as Pharmaceutical Preparations | |
| ZA201505621B (en) | Carbodithioates with spermicidal activity and process for preparation thereof | |
| HK1204525B (en) | Animal barrier and method | |
| ZA201408723B (en) | Emulsion for pharmaceutical use and method for the production thereof | |
| IL240422A0 (en) | Bi-aryl derivatives of propionic acid and their use as medicinal preparations | |
| ZA201506465B (en) | Pharmaceutical preparation | |
| AU2013901352A0 (en) | Investment method and system | |
| GB201308754D0 (en) | Disease monitoring system and method thereof |